BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Acadia Healthcare (ACHC) Down 71% in a Year

  • BioTech Health X
  • September 24, 2025
Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the largest dedicated providers of behavioral health services in the…
Read More
0 Shares
0
0
0
0
0
0
0

Soleno (SLNO) Oversold After 26% Drop

  • BioTech Health X
  • September 24, 2025
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies…
Read More
0 Shares
0
0
0
0
0
0
0

Acadia Pharmaceuticals (ACAD)’s Phase 3 Trial Fails

  • BioTech Health X
  • September 24, 2025
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company headquartered in San Diego, California, dedicated to advancing treatments for…
Read More
0 Shares
0
0
0
0
0
0
0

Cidara (CDTX) Soars on $516.9M Cash War Chest

  • BioTech Health X
  • September 24, 2025
Cidara Therapeutics Inc. (NASDAQ:CDTX) is a biotechnology company dedicated to the discovery, development, and commercialization of novel anti-infectives…
Read More
0 Shares
0
0
0
0
0
0
0

FibroGen (FGEN) Sells China Arm to AstraZeneca in $160M Deal

  • BioTech Health X
  • September 22, 2025
FibroGen Inc. (NASDAQ:FGEN) is a biopharmaceutical company founded in 1993 and headquartered in San Francisco, California, with a…
Read More
0 Shares
0
0
0
0
0
0
0

Flora Growth (FLGC) Soars 69% After $401M AI Pivot

  • BioTech Health X
  • September 22, 2025
Flora Growth Corp. (NASDAQ:FLGC) is a diversified international company that was originally built around natural wellness, cannabis-derived products,…
Read More
0 Shares
0
0
0
0
0
0
0

Zymeworks (ZYME) Reports 153% Revenue Growth, Beats EPS Expectations

  • BioTech Health X
  • September 22, 2025
Zymeworks Inc. (NASDAQ:ZYME) is a clinical-stage biotechnology company that has built its reputation on innovation in the field…
Read More
0 Shares
0
0
0
0
0
0
0

Metsera (MTSR) Shares Soar on Pfizer’s $7.3B Buyout

  • BioTech Health X
  • September 22, 2025
Metsera Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical company founded in 2022 with a focus on developing next-generation therapies…
Read More
0 Shares
0
0
0
0
0
0
0

Quantum BioPharma (QNTM) Eyes $250M in Royalties From Unbuzzd Wellness Deal

  • BioTech Health X
  • September 19, 2025
Quantum BioPharma Ltd. (NASDAQ:QNTM) is a biopharmaceutical company committed to developing innovative therapeutic assets that address some of…
Read More
0 Shares
0
0
0
0
0
0
0

Analysts See 127% Upside for Intellia (NTLA) After $14.99 Surge

  • BioTech Health X
  • September 19, 2025
Intellia Therapeutics Inc. (NASDAQ:NTLA) is a pioneering genome editing company founded in 2014 with the mission to develop…
Read More
0 Shares
0
0
0
0
0
0
0

Oscar Health (OSCR) Reports $2.86B Revenue in Q2 2025

  • BioTech Health X
  • September 19, 2025
Oscar Health Inc. (NYSE:OSCR) is a technology-driven health insurance company founded in 2012 with the mission of making…
Read More
0 Shares
0
0
0
0
0
0
0

UnitedHealth (UNH)’s Q3 Earnings Forecast Crashes Nearly 60%

  • BioTech Health X
  • September 19, 2025
UnitedHealth Group Incorporated (NYSE:UNH) is one of the largest and most influential health care companies in the United…
Read More
0 Shares
0
0
0
0
0
0
0

Syndax (SNDX) Up 15% in 6 Months — Analysts See $56 High

  • BioTech Health X
  • September 17, 2025
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a biotechnology company dedicated to developing innovative therapies that address some of the…
Read More
0 Shares
0
0
0
0
0
0
0

Trulieve Cannabis (TCNNF) Posts $302M Q2 Revenue but Still Reports $14M Net Loss

  • BioTech Health X
  • September 17, 2025
Trulieve Cannabis Corp. (OTC:TCNNF) is one of the largest and most established multi-state cannabis operators in the United…
Read More
0 Shares
0
0
0
0
0
0
0

BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge

  • BioTech Health X
  • September 17, 2025
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is a biotechnology company dedicated to discovering and developing innovative oral therapies for rare…
Read More
0 Shares
0
0
0
0
0
0
0

Novo Nordisk (NVO) Crashes 21.83% in One Day

  • BioTech Health X
  • September 17, 2025
Novo Nordisk A/S (NYSE:NVO) is a global healthcare company with a history that spans more than a century,…
Read More
0 Shares
0
0
0
0
0
0
0

Connect Biopharma (CNTB) Trades at $1.63 With $7.00 Analyst Target

  • BioTech Health X
  • September 17, 2025
Connect Biopharma Holdings Limited (NASDAQ:CNTB) is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative therapies for…
Read More
0 Shares
0
0
0
0
0
0
0

Ocean Biomedical (OCEA) Warned Over Missed $612,581 Milestone

  • BioTech Health X
  • September 17, 2025
Ocean Biomedical, Inc. (NASDAQ:OCEA) is a clinical-stage biopharmaceutical company that was established with a mission to bridge the…
Read More
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Is Catalyst Pharmaceuticals (CPRX) a Smart Rare Disease Stock to Buy for Long-Term Growth?
  • Could Ocular Therapeutix (OCUL) Be a Smart Long-Term Bet in Ophthalmology?
  • Could Aurinia Pharmaceuticals (AUPH) Be a Smart Long-Term Buy After Its Recent Struggles?
  • Is Arcutis Biotherapeutics (ARQT) One of the Most Underrated Biotech Stocks Right Now?
  • Is Trevi Therapeutics (TRVI) the Hidden Biotech Stock Investors Are Missing?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 14, 2026
    Is Catalyst Pharmaceuticals (CPRX) a Smart Rare Disease Stock to Buy for Long-Term Growth?
    • June 14, 2026
    Could Ocular Therapeutix (OCUL) Be a Smart Long-Term Bet in Ophthalmology?
    • June 14, 2026
    Could Aurinia Pharmaceuticals (AUPH) Be a Smart Long-Term Buy After Its Recent Struggles?
    • June 14, 2026
    Is Arcutis Biotherapeutics (ARQT) One of the Most Underrated Biotech Stocks Right Now?
    • June 14, 2026
    Is Trevi Therapeutics (TRVI) the Hidden Biotech Stock Investors Are Missing?
Recent Posts
  • Is Iovance Biotherapeutics (IOVA) a Good Cancer Immunotherapy Stock to Buy Now?
    • June 14, 2026
  • Is Nurix Therapeutics (NRIX) the Kind of Cancer Stock Wall Street Is Sleeping On?
    • June 14, 2026
  • Is Edgewise Therapeutics (EWTX) a Good Long-Term Bet for Biotech Investors?
    • June 14, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (978)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top